LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

Alcon Inc

Gesloten

SectorGezondheidszorg

78.75 -1.78

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

78.48

Max

80.19

Belangrijke statistieken

By Trading Economics

Inkomsten

55M

238M

Verkoop

18M

2.6B

K/W

Sectorgemiddelde

37.557

77.671

EPS

0.79

Dividendrendement

0.41

Winstmarge

9.11

Werknemers

25,000

EBITDA

415M

665M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+14.13% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.41%

2.35%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

2.1B

39B

Vorige openingsprijs

80.53

Vorige sluitingsprijs

78.75

Nieuwssentiment

By Acuity

80%

20%

354 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Alcon Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

9 dec 2025, 18:51 UTC

Acquisities, Fusies, Overnames

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 dec 2025, 15:54 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 dec 2025, 14:32 UTC

Acquisities, Fusies, Overnames

Alcon Upgrades Offer Price for Staar Surgical

12 nov 2025, 09:09 UTC

Winsten
Belangrijke Marktbewegers

Alcon Shares in Switzerland Climb After Guidance Confirmation

7 nov 2025, 15:42 UTC

Acquisities, Fusies, Overnames

Alcon, Staar Surgical Amend Merger Agreement to Allow Other Bids

9 dec 2025, 14:17 UTC

Acquisities, Fusies, Overnames

Alcon Ups Offer Price for Staar Surgical

9 dec 2025, 13:34 UTC

Acquisities, Fusies, Overnames

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 dec 2025, 13:33 UTC

Acquisities, Fusies, Overnames

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 dec 2025, 13:33 UTC

Acquisities, Fusies, Overnames

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 dec 2025, 13:33 UTC

Acquisities, Fusies, Overnames

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9 dec 2025, 13:32 UTC

Acquisities, Fusies, Overnames

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9 dec 2025, 13:32 UTC

Acquisities, Fusies, Overnames

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

9 dec 2025, 13:31 UTC

Acquisities, Fusies, Overnames

Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC

9 dec 2025, 13:31 UTC

Acquisities, Fusies, Overnames

Alcon Announces Amended Merger Agreement With STAAR Surgical

9 dec 2025, 13:31 UTC

Acquisities, Fusies, Overnames

Alcon Enters Amended Merger Agreement for Acquisition of STAAR Surgical >ALC

12 nov 2025, 08:46 UTC

Marktinformatie

Alcon's Guidance Reiteration Offers Relief -- Market Talk

11 nov 2025, 21:35 UTC

Winsten

Alcon 3Q Adj EPS 79c >ALC

11 nov 2025, 21:35 UTC

Winsten

Alcon 3Q Rev $2.61B >ALC.EB

11 nov 2025, 21:35 UTC

Winsten

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11 nov 2025, 21:35 UTC

Winsten

Alcon 3Q EPS 48c >ALC.EB

11 nov 2025, 21:34 UTC

Winsten

Alcon Backs 2025 Adj EPS $3.05-Adj EPS $3.15 >ALC

11 nov 2025, 21:34 UTC

Winsten

Alcon Backs 2025 Net Sales $10.3B-$10.4B >ALC

11 nov 2025, 21:33 UTC

Winsten

Alcon 3Q EPS 48c >ALC

11 nov 2025, 21:33 UTC

Winsten

Alcon 3Q Rev $2.61B >ALC

7 nov 2025, 15:11 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Alcon Waives All Matching Rights for Third-Party Proposals, Info Rights During Go Shop Period >STAA

7 nov 2025, 15:10 UTC

Acquisities, Fusies, Overnames

Staar Surgical: No Termination Fee Payable to Alcon if STAAR Terminates Merger Agreement to Accept a Superior Proposal From a Qualified Bidder >STAA

7 nov 2025, 15:10 UTC

Acquisities, Fusies, Overnames

STAAR Surgical Announces Amendments to Alcon Merger Agreement

27 okt 2025, 12:02 UTC

Acquisities, Fusies, Overnames

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions With Alcon

8 okt 2025, 15:44 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8 okt 2025, 15:44 UTC

Acquisities, Fusies, Overnames

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

Peer Vergelijking

Prijswijziging

Alcon Inc Prognose

Koersdoel

By TipRanks

14.13% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 91.54 USD  14.13%

Hoogste 112.664 USD

Laagste 75.109 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Alcon Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

7

Buy

3

Hold

1

Sell

Technische score

By Trading Central

95.77 / 97.61Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Strong Bullish Evidence

Sentiment

By Acuity

354 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat